| Sex, female |
45.3% |
56.6% |
59.9% |
61.4% |
| Age, in years; mean (SD) |
55.3 (11.2) |
54.5 (11.0) |
53.2 (10.3) |
51.6 (9.8) |
| SES, (3-21), median (1st, 3rd quartile) |
13 (10/17) |
12 (9/16) |
11 (9/15) |
11 (8/14) |
| Depressive symptoms |
|
|
|
|
| Somatic-affective, median (1st/3rd quartile) |
1 (1/2) |
4 (3/4) |
6 (5/7) |
9 (7/10) |
| Cognitive-affective, median (1st,/3rd quartile) |
0 (0/1) |
3 (2/4) |
5 (4/6) |
9 (8/10) |
| Any Anxiety |
3.4% |
18.5% |
55.2% |
86.1% |
| Psychopharmacological treatment |
4.8% |
12.3% |
24.0% |
41.5% |
| Somatic conditions |
|
|
|
|
| Diabetes |
6.9% |
7.6% |
9.0% |
10.5% |
| Diabetes untreated/unaware |
0.7% |
0.4% |
0.5% |
0.4% |
| Obesity (BMI> = 30) |
23.2% |
27.2% |
30.5% |
38.8% |
| Hypertension |
50.1% |
48.7% |
47.3% |
49.6% |
| Dyslipidemia |
28.6% |
29.9% |
34.2% |
35.4% |
| Atrial fibrillation |
2.6% |
2.9% |
2.4% |
3.3% |
| CHD |
4% |
4.7% |
5.5% |
5.8% |
| Myocardial infarction |
2.6% |
3.5% |
3.0% |
3.3% |
| Stroke |
1.6% |
2.0% |
3.1% |
1.8% |
| Cancer |
8.5% |
10.2% |
10.2% |
7.2% |
| > three somatic conditions |
3.0% |
4.0% |
5.1% |
5.7% |
| Health care utilization (last 4 weeks) |
|
|
|
|
| Consulted somatic physicians |
39.4% |
47.1% |
57.9% |
64.6% |
| Consulted psychotherapists/psychiatrists |
0.2% |
0.4% |
2.1% |
9% |
